Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel Contassot

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
Trends in Immunology|October 20, 2009
Lymph node tumor metastases: more susceptible than primary tumors to CD8(+) T-cell immune destructionEmmanuel Contassot, Olivier Preynat-Seauve, Lars French, et al.
Immunotherapy|March 26, 2015
The inflammasome and IL-1β: implications for the treatment of inflammatory diseasesTakashi Satoh, Atsushi Otsuka, Emmanuel Contassot, et al.
Melanoma Research|May 17, 2007
Melanoma-infiltrating dendritic cells induce protective antitumor responses mediated by T cellsOlivier Preynat-Seauve, Emmanuel Contassot, Prisca Schuler, et al.
Gynecologic Oncology|March 30, 2004
Arachidonyl ethanolamide induces apoptosis of uterine cervix cancer cells via aberrantly expressed vanilloid receptor-1Emmanuel Contassot, Mirna Tenan, Valérie Schnüriger, et al.
Dermatology (Basel, Switzerland)|April 13, 2025
Comparison of Acute Generalized Exanthematous Pustulosis with Maculopapular Rash in a Swiss Patient Cohort: A Single-Center Retrospective StudyFabienne Fröhlich, Dominik Wetzstein, Mirjam C Nägeli, et al.
Cancer Research|May 19, 2007
Extralymphatic tumors prepare draining lymph nodes to invasion via a T-cell cross-tolerance processOlivier Preynat-Seauve, Emmanuel Contassot, Prisca Schuler, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 21, 2005
Tumor-infiltrating dendritic cells are potent antigen-presenting cells able to activate T cells and mediate tumor rejectionOlivier Preynat-Seauve, Prisca Schuler, Emmanuel Contassot, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2016
Cytotoxic Cutaneous Adverse Drug Reactions during Anti-PD-1 TherapySimone M Goldinger, Pascale Stieger, Barbara Meier, et al.
The Journal of Investigative Dermatology|August 11, 2018
Genome Editing of Human Primary Keratinocytes by CRISPR/Cas9 Reveals an Essential Role of the NLRP1 Inflammasome in UVB SensingGabriele Fenini, Serena Grossi, Emmanuel Contassot, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|February 8, 2018
Intraperitoneal administration of aluminium-based adjuvants produces severe transient systemic adverse events in miceSandra N Freiberger, Deborah S Leuthard, Agathe Duda, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
Trends in Immunology|October 20, 2009
Lymph node tumor metastases: more susceptible than primary tumors to CD8(+) T-cell immune destructionEmmanuel Contassot, Olivier Preynat-Seauve, Lars French, et al.
Immunotherapy|March 26, 2015
The inflammasome and IL-1β: implications for the treatment of inflammatory diseasesTakashi Satoh, Atsushi Otsuka, Emmanuel Contassot, et al.
Melanoma Research|May 17, 2007
Melanoma-infiltrating dendritic cells induce protective antitumor responses mediated by T cellsOlivier Preynat-Seauve, Emmanuel Contassot, Prisca Schuler, et al.
Gynecologic Oncology|March 30, 2004
Arachidonyl ethanolamide induces apoptosis of uterine cervix cancer cells via aberrantly expressed vanilloid receptor-1Emmanuel Contassot, Mirna Tenan, Valérie Schnüriger, et al.
Dermatology (Basel, Switzerland)|April 13, 2025
Comparison of Acute Generalized Exanthematous Pustulosis with Maculopapular Rash in a Swiss Patient Cohort: A Single-Center Retrospective StudyFabienne Fröhlich, Dominik Wetzstein, Mirjam C Nägeli, et al.
Cancer Research|May 19, 2007
Extralymphatic tumors prepare draining lymph nodes to invasion via a T-cell cross-tolerance processOlivier Preynat-Seauve, Emmanuel Contassot, Prisca Schuler, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 21, 2005
Tumor-infiltrating dendritic cells are potent antigen-presenting cells able to activate T cells and mediate tumor rejectionOlivier Preynat-Seauve, Prisca Schuler, Emmanuel Contassot, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2016
Cytotoxic Cutaneous Adverse Drug Reactions during Anti-PD-1 TherapySimone M Goldinger, Pascale Stieger, Barbara Meier, et al.
The Journal of Investigative Dermatology|August 11, 2018
Genome Editing of Human Primary Keratinocytes by CRISPR/Cas9 Reveals an Essential Role of the NLRP1 Inflammasome in UVB SensingGabriele Fenini, Serena Grossi, Emmanuel Contassot, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|February 8, 2018
Intraperitoneal administration of aluminium-based adjuvants produces severe transient systemic adverse events in miceSandra N Freiberger, Deborah S Leuthard, Agathe Duda, et al.
Pageof 6